Furthermore, EIF1AX mutations, found in 5.4% of our samples, are associated with aggressive thyroid neoplasms, particularly anaplastic thyroid carcinoma [31], and their detection could inform risk stratification and treatment intensity for individual patients. The gene discussed is EIF1AX; the disease is thyroid tumor.